Posted by Amit m on September 28 2026 at 08:41 PM
public
The global alpha 1 antitrypsin deficiency (AATD) treatment market is witnessing considerable growth, supported by the rising prevalence of respiratory disorders, growing awareness of AAT deficien...
A market research and competitive intelligence provider, has estimated that the global lysosomal acid lipase deficiency treatment market will reach approximately USD 1.9 billion by 2036, rising f...
Posted by Surbhi on July 24 2026 at 05:41 PM
public
Setmelanotide (IMCIVREE) — the first FDA-approved melanocortin-4 receptor (MC4R) agonist specifically indicated for proopiomelanocortin (POMC) deficiency-associated obesity representing the targe...
Posted by Surbhi on July 02 2026 at 05:36 PM
public
Proopiomelanocortin deficiency — the ultra-rare monogenic obesity disorder caused by loss-of-function mutations in the POMC gene resulting in early-onset severe obesity, hyperphagia, adrenal insu...
Growth Hormone Deficiency (GHD) clinical management is undergoing a significant transition from a stressful, high-frequency treatment model to a patient-friendly, long-acting therapeutic standard...
